DOT1L and breast carcinoma: Genetic ablation of STING in breast cancer cells attenuated the activation of IFN signaling and growth suppression elicited upon DOT1L inhibition, suggesting the STING pathway contributes to the anti-breast cancer effect of DOT1L inhibition.